Revance’s Botox rival gets FDA approval for painful neck muscle condition
U.S. health regulators have approved expanded use of Revance Therapeutics’ Daxify to treat painful neck muscle ailments, increasing competition from anti-wrinkle injections and AbbVie’s Botox. The approval by the Food and Drug Administration will allow Levans to enter the $2.5 billion U.S. market for neuromodulators that directly act on nerves, the company said Monday. Cervical […]
